Clinical trials
Phase 2 Sarcoma, Ewing trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 5 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Active, not recruiting | 11 |
| Terminated | 5 |
| Recruiting | 4 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 15 |
| Eli Lilly and Company | 3 |
| Children's National Research Institute | 2 |
| Dana-Farber Cancer Institute | 2 |
| M.D. Anderson Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| St. Jude Children's Research Hospital | 2 |
| Children's Oncology Group | 1 |
| Eisai Inc. | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma, Ewing | 46 |
| Rhabdomyosarcoma | 31 |
| Sarcoma | 27 |
| Neuroblastoma | 22 |
| Osteosarcoma | 22 |
| Wilms Tumor | 15 |
| Hepatoblastoma | 13 |
| Medulloblastoma | 13 |
| Ependymoma | 12 |
| Rhabdoid Tumor | 12 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.